1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • September 2016
  • 173 pages
  • ID: 4223473
  • Format: PDF
  • By BCC Research

Summary

Table of Contents

This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021.

Use this report to:
- Gain insight into disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options.
- Analyze diagnostic options and vaccines available for common gastrointestinal conditions.
- Identify the gastrointestinal market landscape as well as important advancements.

Highlights
- The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
- The prescription therapies market is expected to grow from $18.6 billion in 2016 to nearly $22.1 billion in 2021 at a CAGR of 3.5% for the period 2016-2021.
- The diagnostics market over the next five years will grow from $17.7 billion in 2016 to $23.5 billion in 2021 at a CAGR of 5.9% for the period 2016-2021.

STUDY GOALS AND OBJECTIVES
The objective of this study is to present a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. There are two major categories of pharmacological treatment options available for gastrointestinal ailments: prescription drugs and over-the-counter (OTC) drugs.

This report will provide market analysis for the diagnostic options and vaccines available for common gastrointestinal conditions. Markets are further divided by type of therapeutic class of drugs available to treat some of the gastrointestinal conditions. The report provides an overview of the current and projected market with a five-year window for decision-makers interested in the gastrointestinal market arena.

REASONS FOR DOING THE STUDY
This BCC Research study aims to increase the reader’s awareness of gastrointestinal disorders and to identify the gastrointestinal market landscape as well as important advancements. The study analyzes various therapeutic options currently on the market (inline) as well as potential products and classes of products that are likely to have a significant impact on the future (pipeline) for the prescription as well as the over-the-counter (OTC) gastrointestinal drug markets.

The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters. However, manufacturers of gastrointestinal drug products have stepped up the pace of research and development (R&D) as the engine driving growth in all markets, especially those involving new treatments for Crohn’s disease and irritable bowel syndrome (IBS).

INTENDED AUDIENCE
The information and analyses presented in this report are important decision-making tools for managers involved in business development, marketing, market research, product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, and for consultants to the pharmaceutical and biotechnology industry. The study provides a comprehensive analysis of the current and five-year estimated markets for gastrointestinal drugs and, in particular, the market potential of technologies under development in the gastrointestinal diagnostic arena.

SCOPE OF REPORT
This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

As already mentioned, the market for gastrointestinal pharmaceuticals is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals. Similarly, the market for gastrointestinal diagnostics, testing and vaccines is divided into three general segments:
- Diagnostics and testing market.
- Medical devices (endoscopy)
- Vaccines.

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following:
- Gastrointestinal tract disorders.
- Gastrointestinal tract walls disorders.
- Gastrointestinal motility disorders.
- Gastrointestinal cancers.

Each sub-segment is covered in detail, describing the disorders and diseases, identifying currently available and potential products, and competitors.

METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC Research report are based on extensive firsthand interviews with primary executives, product managers and clinical specialists in the gastrointestinal pharmaceutical arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the treatment of gastrointestinal disorders.

Published literature served as the foundation for conducting interviews with various industry participants to obtain (and validate) expert opinions on current and future trends in the gastrointestinal pharmaceuticals industry. Secondary research along with focused interviews were the primary basis for the determination of market size and various market estimations. Interviews as well as findings from bio-medical literature were extensively used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.

All market data pertain to the global market with an emphasis on the U.S. market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year was 2015 and forecast data are provided for 2021. Base year and forecast data are provided for each market segment and sub-segment. Market shares are provided for each market segment for the 2015 base year.

ANALYST’S CREDENTIALS
Yogita Zutshi has 15 years of industry experience working in the areas of clinical operations, medical/regulatory writing and market research experience in the pharmaceutical domain. She has an MS in Clinical Research, an MS in Organic Chemistry, and a Bachelor’s degree in Education. She has also worked on research projects in Clinical Data Management (CDM), and has developed training modules for the clinical and pharmacovigilance areas. She has a high level of proficiency in customized market topline studies, secondary market research and competitive intelligence.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Consumer Health in Myanmar

Consumer Health in Myanmar

  • $ 2100
  • October 2019

This report analyses the market for consumer health in Myanmar. For the purposes of the study, the market has been defined as follows:Consumer Health in Myanmar report offers a comprehensive guide to the ...

Consumer Health in Spain

Consumer Health in Spain

  • $ 2650
  • October 2019

With the Spanish economy continuing to recover and, as a result, the unemployment rate also maintaining a solid downward trajectory, 2019 saw consumer health in Spain record a similarly positive current ...

Consumer Health in Laos

Consumer Health in Laos

  • $ 2100
  • October 2019

Rising incomes and urbanisation are driving sales of consumer health in Laos. More consumers can now afford these products and access the widening range of options available in urban areas, while growing ...

Consumer Health in Sri Lanka $ 2100 October 2019

Consumer Health in Kenya $ 2650 October 2019

Diarrhea - Pipeline Insight, 2020 $ 2000 January 2020


ref:plp2016

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on